Search Results - "Toguchi, Mariko"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Development of an anti-hepatitis B virus (HBV) agent through the structure-activity relationship of the interferon-like small compound CDM-3008 by Takahashi, Nobuaki, Hayashi, Kyohei, Nakagawa, Yusuke, Furutani, Yutaka, Toguchi, Mariko, Shiozaki-Sato, Yumi, Sudoh, Masayuki, Kojima, Soichi, Kakeya, Hideaki

    Published in Bioorganic & medicinal chemistry (01-02-2019)
    “…[Display omitted] Hepatitis B, a viral infectious disease caused by hepatitis B virus (HBV), is a life-threatening disease that leads liver cirrhosis and liver…”
    Get full text
    Journal Article
  2. 2

    Establishment of a Rapid Detection System for ISG20-Dependent SARS-CoV-2 Subreplicon RNA Degradation Induced by Interferon-α by Furutani, Yutaka, Toguchi, Mariko, Higuchi, Shoko, Yanaka, Kaori, Gailhouste, Luc, Qin, Xian-Yang, Masaki, Takahiro, Ochi, Sae, Matsuura, Tomokazu

    “…Inhaled nebulized interferon (IFN)-α and IFN-β have been shown to be effective in the management of coronavirus disease 2019 (COVID-19). We aimed to construct…”
    Get full text
    Journal Article
  3. 3

    Phenosafranin inhibits nuclear localization of transglutaminase 2 without affecting its transamidase activity by Furutani, Yutaka, Toguchi, Mariko, Shrestha, Rajan, Kojima, Soichi

    Published in Amino acids (01-03-2017)
    “…Transglutaminase 2 (TG2) localizes to the nucleus and induces apoptosis through a crosslinking inactivation of Sp1 in JHH-7 cells treated with acyclic…”
    Get full text
    Journal Article
  4. 4

    An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes by Furutani, Yutaka, Toguchi, Mariko, Shiozaki-Sato, Yumi, Qin, Xian-Yang, Ebisui, Etsuko, Higuchi, Shoko, Sudoh, Masayuki, Suzuki, Harukazu, Takahashi, Nobuaki, Watashi, Koichi, Wakita, Takaji, Kakeya, Hideaki, Kojima, Soichi

    Published in PloS one (12-06-2019)
    “…Oral administration of nucleotide analogues and injection of interferon-α (IFNα) are used to achieve immediate suppression in replication of hepatitis B virus…”
    Get full text
    Journal Article
  5. 5